Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

2023 in Retrospect: Pivotal Developments in Critical Care

Houston Methodist

D. Bangalore Gotur, J. Munoz, A. Zuckerman, E. Park, J. Minneman

Withdrawal of Voxelotor: Implications for Clinical Practice in Sickl…

Akshat Jain

Managing Benign Hematology Disorders

Indy Hematology Review

C. Kessler

Anemia and Thrombocytopenia Basics

UNC Lineberger Comprehensive Cancer Center

N. Vogler

Understanding CRISPR and Gene Editing in the Treatment of Heme Malig…

UChicago Medicine

A. Cooper

Severe Anemia: Indications for Blood Transfusion, Initial Work Up, a…

APP2APP Virtual Lectures, Inc

D. Thomas

aTTP: Current Management Based on Real-World Data

Joan Cid

Preventing Relapse in iTTP

Senthil Sukumar

A Multidisciplinary Team Approach to TTP

Penn Medicine Abramson Cancer Center

D. Siegel

Hospital Management and Care for Patients With aTTP

Cedars Sinai

J. Lorber

iTTP vs. Atypical HUS: Work-Up, Diagnosis, and Initial Treatment

USTMA - The United States Thrombotic Microangiopathy Consortium

S. Agarwal

Highlights in Red Cell and Platelet Disorders From ASH 2023

Insights from 2023 ASH Annual Meeting

M. Blinder

ACP 2024 Insights: Sickle Cell Anemia - Diagnosis and Management of …

Insights from 2024 ACP Annual Meeting

M. Okam Achebe

Experts Discuss Current Initial Treatment Approaches in TTP

BMFcases

T. Bat, S. Cataland

Role of Antiplatelet and Anticoagulant Therapy: Managing Vaso-Occlus…

Erica Sparkenbaugh

Outcomes of Lovo-Cel Gene Therapy in Sickle Cell Disease: 60-Month F…

Yale Cancer Center

J. Ryu

Updates in Cellular Therapy for Sickle Cell Disease and Beta-Thalass…

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

S. Peslak

Recent Gene Therapy Approvals in SCD: Clinical and Logistical Consid…

Nirmish Shah

IDWeek 2024 Insights: Early Discontinuation of Empiric Antibiotics f…

IDWeek 2024 Insights

S. Castejon Ramirez